Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Current Deferred Revenue (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Current Deferred Revenue for 17 consecutive years, with $95.0 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 57.21% to $95.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.0 million through Dec 2025, down 57.21% year-over-year, with the annual reading at $95.0 million for FY2025, 57.21% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $95.0 million at Bristol Myers Squibb, down from $190.0 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $367.0 million in Q1 2021, with the low at $95.0 million in Q4 2025.
  • Average Current Deferred Revenue over 5 years is $266.0 million, with a median of $276.0 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue grew 23.33% in 2024, then crashed 57.21% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $330.0 million in 2021, then tumbled by 32.73% to $222.0 million in 2022, then dropped by 18.92% to $180.0 million in 2023, then rose by 23.33% to $222.0 million in 2024, then plummeted by 57.21% to $95.0 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $95.0 million, $190.0 million, and $203.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.